OQS
SANA icon

Occudo Quantitative Strategies’s Sana Biotechnology SANA Stock Holding History

Occudo Quantitative Strategies’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-129,204
Closed -$770K – 1276
2023
Q2 		$770K Buy
129,204
+68,635
+113% +$396K 0.08% 407
2023
Q1 		$198K Buy
+60,569
New +$242K 0.02% 757
2022
Q4 		– Sell
-48,411
Closed -$290K – 1320
2022
Q3 		$290K Buy
+48,411
New +$349K 0.02% 856
2022
Q2 		– Sell
-96,013
Closed -$793K – 1356
2022
Q1 		$793K Buy
+96,013
New +$776K 0.07% 462

Other funds holding SANA

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Occudo Quantitative Strategies's SANA Position: Q3 2023 in Review

Occudo Quantitative Strategies sold out of Sana Biotechnology (SANA) in Q3 2023, closing a stake of 129,204 shares — an estimated $770K sold.

Occudo Quantitative Strategies first reported a position in SANA in Q1 2022 and held it in 4 quarters. The position peaked at $793K in Q1 2022. 136 funds tracked by Wall St. Rank hold SANA as of Q3 2023.

  • Occudo Quantitative Strategies reported no remaining Sana Biotechnology position as of Q3 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 129,204 Sana Biotechnology shares in Q3 2023, an estimated $770K.
  • Occudo Quantitative Strategies first reported a position in Sana Biotechnology in Q1 2022 and held it in 4 quarters.
  • Occudo Quantitative Strategies's Sana Biotechnology position peaked at $793K in Q1 2022.
  • 136 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.